Yanling Chen
Suzhou, 215003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
An Integrated Transcriptional and Post-Transcriptional Regulatory Circuit Orchestrated by NUDT21 Maintains the Proliferation and Survival of Neuroblastoma.
Journal: Neuro-oncology
Published: December 26, 2025
NeuroD1-USP1-MYCN axis drives tumor progression in neuroblastoma.
Journal: Journal of translational medicine
Published: October 07, 2025
Targeting super-enhancer-driven MAB21L2 suppresses neuroblastoma growth and migration.
Journal: Experimental cell research
Published: July 08, 2025
KIF11 promotes AML progression, and its inhibition by SB-743921 suppresses disease advancement through mitotic G2/M phase arrest.
Journal: Cellular signalling
Published: June 03, 2025
NVP-2, in combination with Orlistat, represents a promising therapeutic strategy for acute myeloid leukemia.
Journal: Cancer biology & therapy
Published: January 12, 2025
The super-enhancer regulatory gene SH2D1A promotes the progression of T cell acute lymphoblastic leukemia by activating CHI3L2.
Journal: Cellular signalling
Published: January 06, 2025
USP20 as a super-enhancer-regulated gene drives T-ALL progression via HIF1A deubiquitination.
Journal: Acta pharmaceutica Sinica. B
Published: November 12, 2024
Super-Enhancer-Driven IRF2BP2 is Activated by Master Transcription Factors and Sustains T-ALL Cell Growth and Survival.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 25, 2024
Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation.
Journal: Neuro-oncology
Published: June 12, 2024
Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 24, 2024
Enhancer looping protein LDB1 modulates MYB expression in T-ALL cell lines in vitro by cooperating with master transcription factors.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 28, 2024
Last Updated: 09/26/2026